US Broker Ratings

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Exploring a Remarkable 180% Potential Upside

Atrium Therapeutics, Inc. (NASDAQ: RNA), a pioneering player in the biotechnology sector, has captured the attention of investors with its innovative approach to RNA therapeutics for..

Telix Pharmaceuticals Limited (TLX): Investor Outlook on a Biotech with 124% Potential Upside

Telix Pharmaceuticals Limited (TLX) is capturing the attention of investors with its promising pipeline in the biotechnology sector. This Australia-based company, which specializes in therapeutic and..

Teleflex Incorporated (TFX) Stock Analysis: Unveiling a 12.99% Potential Upside in Medical Device Sector

Teleflex Incorporated (NYSE: TFX), a stalwart in the healthcare sector, operates within the medical instruments and supplies industry, boasting a market capitalization of $5.77 billion. Headquartered..

BrightSpring Health Services (BTSG) Stock Analysis: 31.33% Upside Potential Captivates Investors

BrightSpring Health Services, Inc. (BTSG) is emerging as a notable player within the Healthcare sector, specifically in the Health Information Services industry. Based in Louisville, Kentucky,..

iRhythm Holdings, Inc. (IRTC) Stock Analysis: Navigating a 41% Potential Upside in the Medical Device Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC), a prominent player in the healthcare sector, has been intriguing investors with its ambition to redefine cardiac monitoring through innovative device-based..

Revvity, Inc. (RVTY) Stock Analysis: Navigating the Diagnostics & Research Landscape with a Strong Market Presence

Revvity, Inc. (NYSE: RVTY), a key player in the healthcare sector, specifically within the diagnostics and research industry, presents an intriguing investment opportunity for those keen..

Corcept Therapeutics (CORT) Stock Analysis: A Promising 64% Upside Awaits Investors

Corcept Therapeutics Incorporated (NASDAQ: CORT) is making waves in the biotechnology sector with its innovative approach to treating severe endocrinologic, oncologic, metabolic, and neurologic disorders. As..

Lantheus Holdings, Inc. (LNTH) Investor Outlook: Unveiling Growth Potential with a 7.20% Upside and Robust ROE

Investors have their eyes on Lantheus Holdings, Inc. (NASDAQ: LNTH), as the company stands at a pivotal juncture within the healthcare sector. With a market capitalization..

Charles River Laboratories (CRL) Stock Analysis: Navigating a Challenging Landscape with Strategic Resilience

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a pivotal entity in the healthcare sector, specifically within the diagnostics and research industry. With a robust..

ADMA Biologics Inc (ADMA): Analyst Consensus Reveals 59% Upside Potential for Investors

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, is presenting an intriguing opportunity for investors looking to capitalize on the healthcare industry’s..

Krystal Biotech, Inc. (KRYS) Investor Outlook: Assessing a 26.95% Potential Upside Amidst Biotech Innovations

Krystal Biotech, Inc. (NASDAQ: KRYS) is a prominent player in the biotechnology sector, making waves with its innovative approach to genetic medicines. With a market capitalization..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Exploring an Attractive 78% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK), a key player in the biotechnology sector, commands attention with its innovative approach to muscle biology. The company, headquartered in South San..

Bio-Techne Corp (TECH) Stock Analysis: Navigating a Growth Path in a Challenging Biotechnology Landscape

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the biotechnology sector, stands at a pivotal crossroads as it navigates the complexities of the healthcare industry. With..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A Promising 57.80% Potential Upside in Biotech

For investors seeking opportunities in the biotechnology sector, Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) presents a compelling case. With a focus on innovative treatments for metabolic dysfunction-associated..

Repligen Corporation (RGEN) Stock Analysis: Navigating a 13.86% Potential Upside

Investors with an eye for growth in the healthcare sector may find Repligen Corporation (NASDAQ: RGEN) an intriguing proposition. A key player in the medical instruments..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 12.30% Upside Potential in the Healthcare Sector

Takeda Pharmaceutical Company Limited (NYSE: TAK) stands as a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Evaluating a 57% Potential Upside

For investors with a keen eye on the biotechnology sector, Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) presents a compelling opportunity, driven by its focus on rare neuroendocrine..

Alkermes plc (ALKS) Stock Analysis: Exploring a 28.83% Potential Upside in the Biopharmaceutical Sector

Alkermes plc (NASDAQ: ALKS) stands out in the healthcare sector as a biopharmaceutical company with a focus on addressing unmet medical needs across various therapeutic areas...

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A 24.56% Potential Upside in the Diagnostics & Research Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the diagnostics and research industry, stands as a compelling opportunity for investors eyeing growth in the healthcare..

Waters Corporation (WAT) Stock Analysis: A Healthcare Giant with 113% Revenue Growth and Strategic Upside

Waters Corporation (NYSE: WAT), a behemoth in the Healthcare sector, operates within the Diagnostics & Research industry and has captured investor attention with its impressive revenue..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds